FDA drug company registration is a mandatory compliance requirement for all pharmaceutical manufacturers, repackers, relabelers, and distributors involved in the U.S. drug supply chain. Any company that manufactures or handles drugs intended for the United States must register its establishment with the U.S. Food and Drug Administration and properly list its drug products.
Drug establishment registration allows the FDA to identify manufacturing locations and monitor compliance with U.S. regulatory standards. Along with registration, drug listing ensures that every marketed drug is accurately reported with formulation, labeling, and manufacturing details. This system helps the FDA maintain product traceability, enforce safety regulations, and protect public health.
The FDA drug registration process is completed electronically through the FDA’s structured submission systems. Companies must submit establishment information, manufacturing activities, and drug listing data, including dosage form, route of administration, and labeling details. Upon successful submission, the FDA assigns an Establishment Identifier (FEI) number, which is used for inspections and regulatory tracking.
It is important to note that FDA registration does not mean FDA approval. Registration simply confirms that the facility and products are properly listed with the agency. Approval is a separate regulatory step that applies to specific drug applications such as ANDA or NDA submissions.
FDA drug company registration must be completed initially before marketing and renewed annually between October 1 and December 31. Failure to register or list drugs correctly can lead to serious consequences, including product delisting, import refusal, warning letters, or regulatory enforcement actions.
For foreign drug manufacturers, appointing a U.S. Agent is compulsory. The U.S. Agent acts as the official communication point between the FDA and the overseas company, especially during inspections or compliance queries.
Because FDA drug registration involves technical data formats, regulatory accuracy, and strict timelines, many companies prefer professional assistance. XPRO America, a trusted US FDA Consultancy, supports pharmaceutical companies worldwide with end-to-end FDA drug establishment registration, drug listing, U.S. Agent services, and ongoing compliance management.
If you need expert guidance to register your drug company with the FDA or resolve listing issues, you can reach the regulatory specialists at support@xproamerica.com for personalized assistance tailored to your business needs.
Leave a Reply